Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-14

Clinical Trial Update: Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component [NA]

View source ↗

Summary

Clinical trial update for the SOCA study evaluating foscarnet-ganciclovir in CMV retinitis associated with AIDS; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cytovene (ganciclovir)
  • Foscarnet (foscarnet)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Retinitis, HIV Infections | NA | Status: COMPLETED